Читать книгу Practical Cardiovascular Medicine - Elias B. Hanna - Страница 86

1 143. Doyle BJ, Rihal CS, Gastineau DA, Holmes DR. Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice. J Am Coll Cardiol 2009; 53: 2019–27.

2 144. Rao SV, Jollis JG, Harrington RA, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555–62. +from Crusade registry: Alexander KP, Chen AY, Wang TY, et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J 2008; 155: 1047–53.

3 145. A randomized trial of liberal vs. restrictive red blood cell transfusion strategies in patients with acute myocardial infarction and anemia. Presented by Steg PG, at ESC 2020.

4 146. Steg PG, Hubert K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J 2011; 32: 1854–64.

5 147. Hanna EB, Alexander KP, Chen AY, et al. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction undergoing an invasive strategy according to hemoglobin levels. Am J Cardiol 2013; 111(8): 1099–103.

6 148. Hurlen M, Abdelnoor M, Smith P, Erikssen J, Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 2002; 347: 969–74. WARIS 2.

7 149. Van ES, Jonker JJ, Verheugt FWA, et al. Aspirin and Coumadin after acute coronary syndromes (the ASPECT-2 study). Lancet 2002; 360: 109–11.